Work

Heterogeneous cost-control pathways of DRG payment reform and associated risks in stroke care: A multicentre quasi-experimental study

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background China's DRG payment reform targets healthcare cost containment, yet whether cost reductions translate into genuine efficiency gains or billing adaptation—and what this means for clinical quality and patient financial protection—remains unclear, particularly across hospitals of varying institutional capacity. Methods We analyzed 2019 and 2023 discharge records from three tertiary hospitals representing distinct economic development contexts: Dalian (developed, n = 13,726), Zhuzhou (mid-income, n = 7,297), and Zhumadian (underdeveloped, n = 12,391). Propensity score matching, interrupted time series, quantile regression, mediation analysis, and Oaxaca-Blinder decomposition were applied to characterise reform effects and mechanisms. Monte Carlo simulation across ten periods and five policy scenarios projected counterfactual outcomes. Results Mean hospitalisation costs fell by 11.1% at Dalian, 20.1% at Zhuzhou, and 36.3% at Zhumadian (pooled − 23.2%; I²=99.4%). At Dalian, pharmaceutical costs fell from 33.4% to 18.2% while diagnostic imaging and nursing shares were preserved; mediation analysis attributed 62.1% of the cost reduction to clinical pathway changes. At Zhumadian, pharmaceutical expenditure dropped by 27.6 percentage points but was largely offset by expansion of "other costs" from 30.2% to 64.8%; only 30.1% of the reduction was mediated through clinical pathways. Oaxaca-Blinder decomposition revealed that 85.2% of cross-site cost differentials stemmed from hospital behavioural differences rather than patient case-mix. In-hospital mortality declined uniformly across sites (adjusted ORs 0.60–0.64). However, hospital-acquired pneumonia and deep vein thrombosis rates increased at Zhuzhou and Zhumadian (adjusted ORs 1.42–1.73; E-values 2.21–2.89). Out-of-pocket expenditure decreased at Dalian (− 8.3%) but rose at Zhumadian (+ 9.4%), where catastrophic health expenditure increased from 24.6% to 31.2% despite the largest absolute cost reduction. Simulation showed that DRG alone raised the quality risk index to 0.114 by period nine, whereas coupling DRG with behavioural regulation held the index at 0.105 while achieving greater cost reduction (− 13.6%). Conclusions DRG reform achieved cost containment through different mechanisms depending on institutional context. Where governance capacity was limited, cost reductions were driven largely by expenditure reclassification rather than care optimisation, and were accompanied by deterioration in nursing-sensitive quality indicators and worsening patient financial burden. Effective implementation requires differentiated strategies that match governance investment to institutional capacity and ensure that insurance benefit design keeps pace with payment reform.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7236351406
Cites: 21
Cited by:
Related to: 10